1. A phase II trial of BAY 43‐9006 (sorafenib) (NSC‐724772) in patients with relapsing and resistant multiple myeloma: SWOG S0434. (10th June 2014) Authors: Srkalovic, Gordan; Hussein, Mohamad A.; Hoering, Antje; Zonder, Jeffrey A.; Popplewell, Leslie L.; Trivedi, Harsha; Mazzoni, Sandy; Sexton, Rachel; Orlowski, Robert Z.; Barlogie, Bart Journal: Cancer medicine Issue: Volume 3:Number 5(2014:Oct.) Page Start: 1275 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗